February 17th, 2021 Comments Off on Management
Management
- Fb
- Tw
- Pin
Recent Posts
- Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease
- Late-Breaking Interim STENOVA Data for AGMB-129 in Fibrostenosing Crohn’s to be Presented at Digestive Disease Week® 2025
- Agomab Announces Positive Topline Phase 2a Interim Results for AGMB-129 in Fibrostenosing Crohn’s Disease
- Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors
- Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis- focused Pipeline
